Clin Osteol 2004; 9(1): 16-17
A critical analysis of the WHI study from the point of view of prevention and management of osteoporosisArticles
The WHI study was done with a population that greatly differs from the current population ofmenopausal women. To apply its results in practice israther difficult. The mean age of the women was 63 years - and even the oldest women were given the same dose of conjugated estrogens (0.625 mg). For years now we have been administering to older women lower estrogen doses and, moreover, we have at our disposal preparations with modern ges tagens (dydrogesterone, dienogest) or tibolone.
Keywords: WHI, estrogens, tibolone, osteoporosis.
Published: June 11, 2004 Show citation
References
- Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
Go to original source... - Hays J, Ockene JK, Brunner RL, et al. Effectss of Estrogen plus Progestin on Health-Related Quality of Life. N Engl J Med 2003;348:1839-1854.
Go to original source... - Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus Progestin and the Inci dence of Dementia and Mild Cognitive Impairment in Postmenopausal Women, The Womens' Health Initiative Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2651-2662.
Go to original source... - Rapp SR, Espeland MA, Shumaker SA, et al. Effect of Estrogen plus Progestin on Global Cognitive Function in Postmenopausal Women, The Womens Health Initia tive Memory Study: A Randomized Controlled Trial. JAMA 2003;289:2663-2671.
Go to original source... - Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of Estrogen plus Pro gestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, The Womens Health Initiative Randomized Trial. JAMA 2003;289:3243-3253.
Go to original source... - Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. WHI Investigators. Effect of Estrogen plus Progestin on Stroke in Postmenopausal Women, The Women's Health Initiative: a Randomized Trial. JAMA 2003;289:2673-2684.
Go to original source... - Hendrix Sl. Hormone therapy: evolving concepts. Curr Opin Rheumatol 2003; 15:464-8.
Go to original source... - Rymer J, Robinson J, Fogelman I. Ten years of treatment with tibolone 2,5 mg daily: effects on bone loss in postmenopausal women. Climacetric 2002;5:226-42. inzerát Biomin
Go to original source...

